Child and Adolescent Anxiety Disorders (CAMS)

Completed · Phase 3 · Has a placebo group

Conditions studied: Anxiety Disorders, Social Phobia, Generalized Anxiety Disorder

In brief

This randomized, controlled trial compared the efficacy of the medication sertraline (Zoloft®), cognitive-behavioral therapy, the combination of these treatments, and placebo for youth with anxiety disorders.

Key facts

Study ID

NCT00052078

Run by

Johns Hopkins University

People needed

488

Starts

2003-01-01

Expected to finish

2008-03-01

Last updated by the study team

2017-09-19

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for separation anxiety disorder, social phobia, or generalized anxiety disorder

You may not qualify if…

• Major neurological disorder or medical illness that would interfere with participation in the study

Where it is running

• UCLA — Los Angeles, California, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• NYSPI/Columbia University — New York, New York, United States
• Duke University — Durham, North Carolina, United States
• Temple University — Philadelphia, Pennsylvania, United States
• University of Pittsburgh/WPIC — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.